Achromobacter Bacteremia in Immunocompromised Patients With Malignancy: A Case Series Highlighting Diagnostic and Therapeutic Challenges

View at publisher Summarise with VIRAT
Authors: David S. Kornblum, Israel Rosero Basurto, JN Greene
Cited by: 0
References: 19

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Objectives: Achromobacter species are increasingly recognized as opportunistic pathogens in immunocompromised patients, yet contemporary data on Achromobacter bacteremia in patients with malignancy are limited. We describe a case series highlighting clinical presentations, antimicrobial resistance patterns, and outcomes in this high-risk population. Materials and Methods: We describe 3 cases of Achromobacter bacteremia in patients with hematologic malignancies at a tertiary cancer center. Clinical features, presumed sources of infection, antimicrobial susceptibilities, management strategies, and outcomes were reviewed. Results: The cases demonstrated heterogeneous routes of infection, including probable skin barrier translocation, delayed focal suppuration following bacteremia, and secondary bacteremia from necrotizing soft tissue infection. All patients were profoundly immunocompromised with prolonged neutropenia and prior antimicrobial exposure. Progressive antimicrobial resistance occurred in 2 cases, necessitating escalation to salvage therapies. Clinical outcomes were closely associated with the feasibility of source control and immune recovery; 1 patient recovered after surgical drainage and neutrophil reconstitution, whereas 2 experienced infection-related mortality. Conclusions: Achromobacter bacteremia represents a serious and potentially fatal infection in patients with malignancy. Management is challenged by antimicrobial resistance, recurrence, and host immunosuppression. Outcomes depend more on immune recovery and source control than antimicrobial therapy alone, underscoring the need for heightened vigilance and susceptibility-guided treatment strategies.

Fields of Study & Subjects

Infections and bacterial resistance Neutropenia and Cancer Infections Antibiotic Resistance in Bacteria

Publication details

Journal / source
Infectious Diseases in Clinical Practice
Volume
34
Issue
3
Publication date
30 March 2026
Language
EN